Kevin Hern, Republican congressman from Oklahoma's First District, is making the rounds on financial news aggregators today after Investing.com flagged his latest disclosed positions in Exxon Mobil and Honeywell Aerospace. One story. One day. The headline writes itself for a member of Congress who sits on the Ways and Means Committee and has filed five disclosed trades in the last 90 days. Here's what the public record actually shows when you look past the press release version.
The News That Got Him Here
The story making the rounds cites Hern picking up shares in Exxon Mobil and Honeywell Aerospace. The Bluesky crowd noticed too: disclosure trackers flagged a Honeywell Aerospace exchange transaction dated June 29, 2026, listed at $15,001. The amount is the federal minimum for required reporting. Whether that's a meaningful position or a rounding error in a man's portfolio is a judgment call the filings leave entirely to you.
Hern represents Tulsa. He's an oil-patch congressman in the most literal sense, geographically speaking. Exxon Mobil is, to put it gently, not a counterintuitive pick for that zip code. The question worth asking isn't whether an Oklahoma Republican owns energy stocks. Of course he does. The question is what the full trading record looks like across 74 scored transactions.
The Last 90 Days, Specifically
Per Blind Trust's disclosure record for Hern, five trades have been filed in the last 90 days. Here's the tape:
- May 8, 2026: Exchange transaction in Coterra Energy (CTRA), $15,001-$50,000
- May 8, 2026: Exchange transaction in Devon Energy (DVN), $15,001-$50,000
- May 8, 2026: Sale of Coterra Energy (CTRA), $15,001-$50,000
- May 8, 2026: Sale of Devon Energy (DVN), $15,001-$50,000
- April 29, 2026: Sale of Goldman Sachs (GS), $250,001-$500,000
Four of those five trades touch energy companies. Coterra and Devon are both oil and gas producers. He exchanged and then sold out of both on the exact same day. Goldman Sachs got cut loose the week before, in a position worth up to half a million dollars.
The Goldman sale is the one that sits differently. Ways and Means doesn't oversee banking. That trade carries no committee-level angle. It's just a large sale of a major financial institution by a sitting congressman. The math on it won't be available in this 90-day window, but it's the largest disclosed transaction in the recent set by a significant margin.
The Overall Record: 31 Wins, 43 Losses, Across 74 Trades
Here's where it gets less flattering for the thesis that congressional trading is some kind of systematic edge operation.
Across 74 scored transactions, Hern is 31-for-74 on positive 30-day alpha versus the S&P 500. That's a 41.9% hit rate. His mean 30-day alpha across all scored trades is negative 1.0%. He has, on average, slightly underperformed simply owning the index and going to committee hearings.
The worst entries are notable. In October 2025, he filed two separate sales of BNPQY (BNP Paribas ADR) on the same day: one in the $1,000,001-$5,000,000 range, one in the $250,001-$500,000 range. Both logged a 30-day alpha of negative 14.1%. A Progress Software (PRGS) sale in March 2026 came in at negative 20.3% alpha. These aren't cherry-picked lowlights from a good overall record. The overall record is 31-for-74.
The best trades on record: a Chubb (CB) purchase in July 2024 that logged plus-13.3% alpha over 30 days, a UnitedHealth Group (UNH) purchase in June 2024 at plus-12.8%, and a Lockheed Martin (LMT) purchase the same month at plus-12.3%.
Two of those three best trades have a committee angle worth naming.
Ways and Means: The Trades That Actually Matter Here
Hern sits on Ways and Means, specifically the Health and Tax subcommittees. That committee's jurisdiction covers healthcare financing, Medicare, Medicaid, and health insurance policy. Five of his scored trades overlap with sectors directly inside that remit.
The UnitedHealth Group purchase in June 2024, filed at $1,001-$15,000, returned plus-12.8% alpha over the following 30 days. That's a health insurance company traded by a member of the committee that sets healthcare reimbursement rules. The same position was sold in December 2025 for $250,001-$500,000, at plus-2.0% alpha. That's a significant scale-up between the purchase and the sale, though the filings show the amounts in wide ranges so the exact appreciation is unrecoverable from the disclosure data alone.
A Chubb (CB) purchase in July 2024 cleared at plus-13.3% alpha. Chubb is a major insurance holding company. Ways and Means has jurisdiction over insurance policy in certain contexts, and Hern's committee assignment includes a Health subcommittee role. That's the overlap that earns the notation, not a conspiracy theory.
Johnson and Johnson (JNJ), purchased March 2024 at minus-0.2% alpha. Boston Scientific (BSX), sold October 2025 at minus-0.4% alpha. Both in the committee's healthcare orbit. Both flat-to-negative on the 30-day measure. The committee overlap didn't print money on those two.
The honest summary: five committee-overlap trades. Two posted double-digit positive alpha. Three were flat or slightly negative. It's a small sample. Make of the pattern what you make of it.
The Votes Nearby
Hern's recent floor votes don't create any neat overlap with the five trades in the 90-day window. No vote-trade pair in the disclosure data lines up closely enough to flag on timing alone. The data shows no vote_trade_overlaps in the structured record.
What he did vote on recently: the Protecting Privacy in Purchases Act (H.R. 1181, July 14, Yea, Passed) and the TRIA Program Reauthorization Act of 2026 (H.R. 7128, June 29, Yea, Passed). TRIA reauthorizes the federal terrorism risk insurance backstop, which is meaningfully relevant to insurance sector companies. Hern voted Yea on June 29. The Honeywell Aerospace exchange transaction is also dated June 29. Honeywell Aerospace is not an insurance company. The Venn diagram doesn't connect. The dates are the same and the industries are different, so the coincidence, such as it is, dissolves on inspection.
The Financial Exploitation Prevention Act of 2025 (H.R. 2478, June 25, Yea, Passed) and the 21st Century ROAD to Housing Act (H.R. 6644, June 23, Yea, Passed) round out the recent vote ledger. None of those carry a clean line to the energy or financial trades filed in the same period.
What the Record Actually Shows
Hern is trending today because a financial aggregator noticed his Exxon Mobil and Honeywell Aerospace disclosures. That's a fair thing for financial aggregators to notice. He's a sitting congressman. His trades are public by law. The institutional deadpan version: members are required to disclose. They are not required to divest, recuse, abstain, or pick stocks that beat the market.
On that last point, Hern's record does the work. Seventy-four scored trades. Thirty-one positive. Mean 30-day alpha of negative one percent. He's underperforming a passive index fund while filing disclosures that generate coverage cycles like today's.
The committee-overlap trades are the ones the rulebook says to watch. Five trades inside Ways and Means jurisdiction. Two posted strong alpha. Three didn't. It's not a clean story in either direction.
His full trading history is public at Blind Trust's Kevin Hern disclosure page. The receipts are public. Make of them what you make of them.